Equities Analysts Offer Predictions for COO FY2025 Earnings

Key Points

• Zacks Research has increased its FY2025 earnings estimate for Cooper Companies from $4.05 to $4.09 per share, higher than the current consensus of $3.98.
• Cooper Companies has announced a $2.00 billion stock buyback plan, indicating management's belief that the stock is undervalued.
• The company's recent quarterly earnings report showed an EPS of $1.10, exceeding estimates, while revenue grew by 5.7% year-over-year.

The Cooper Companies, Inc. (NASDAQ:COO - Free Report) - Equities researchers at Zacks Research upped their FY2025 earnings estimates for shares of Cooper Companies in a research note issued to investors on Wednesday, September 17th. Zacks Research analyst Team now anticipates that the medical device company will post earnings of $4.09 per share for the year, up from their previous estimate of $4.05. The consensus estimate for Cooper Companies' current full-year earnings is $3.98 per share. Zacks Research also issued estimates for Cooper Companies' Q2 2026 earnings at $1.04 EPS, Q3 2026 earnings at $1.14 EPS, Q4 2026 earnings at $1.17 EPS, FY2026 earnings at $4.35 EPS, Q1 2027 earnings at $1.10 EPS, Q2 2027 earnings at $1.15 EPS, Q3 2027 earnings at $1.25 EPS and FY2027 earnings at $4.77 EPS.

COO has been the subject of several other research reports. BNP Paribas raised Cooper Companies from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, July 22nd. Wall Street Zen downgraded shares of Cooper Companies from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. Loop Capital set a $100.00 target price on shares of Cooper Companies in a research note on Tuesday, June 17th. Stifel Nicolaus cut their target price on shares of Cooper Companies from $90.00 to $85.00 and set a "buy" rating for the company in a research note on Thursday, August 28th. Finally, Piper Sandler lowered their price target on Cooper Companies from $105.00 to $83.00 and set an "overweight" rating for the company in a report on Thursday, August 28th. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $86.64.

Cooper Companies Trading Down 1.3%

NASDAQ:COO opened at $64.32 on Thursday. The company has a market capitalization of $12.79 billion, a PE ratio of 31.68, a price-to-earnings-growth ratio of 1.71 and a beta of 0.97. The company has a quick ratio of 1.24, a current ratio of 2.12 and a debt-to-equity ratio of 0.29. Cooper Companies has a 52-week low of $61.78 and a 52-week high of $112.29. The stock has a fifty day simple moving average of $70.98 and a 200-day simple moving average of $75.48.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.07 by $0.03. The company had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The business's revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS.

Cooper Companies declared that its board has approved a stock buyback plan on Wednesday, September 17th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the medical device company to repurchase up to 15.4% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's management believes its stock is undervalued.

Insider Buying and Selling

In related news, COO Gerard H. Warner III purchased 1,450 shares of the firm's stock in a transaction on Friday, September 5th. The stock was purchased at an average price of $69.23 per share, for a total transaction of $100,383.50. Following the acquisition, the chief operating officer directly owned 18,319 shares in the company, valued at $1,268,224.37. The trade was a 8.60% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Albert G. White III bought 10,000 shares of Cooper Companies stock in a transaction dated Friday, September 5th. The shares were acquired at an average price of $68.39 per share, with a total value of $683,900.00. Following the completion of the purchase, the chief executive officer owned 226,151 shares in the company, valued at approximately $15,466,466.89. The trade was a 4.63% increase in their position. The disclosure for this purchase can be found here. Insiders have bought 15,975 shares of company stock worth $1,079,566 in the last 90 days. 1.98% of the stock is owned by insiders.

Hedge Funds Weigh In On Cooper Companies

Institutional investors and hedge funds have recently made changes to their positions in the business. Zions Bancorporation National Association UT purchased a new position in shares of Cooper Companies during the 1st quarter valued at approximately $33,000. City Holding Co. purchased a new position in shares of Cooper Companies during the 1st quarter valued at approximately $34,000. GKV Capital Management Co. Inc. purchased a new position in shares of Cooper Companies during the 1st quarter valued at approximately $40,000. J.Safra Asset Management Corp boosted its stake in shares of Cooper Companies by 204.8% during the 2nd quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company's stock valued at $36,000 after buying an additional 340 shares during the last quarter. Finally, CYBER HORNET ETFs LLC purchased a new position in shares of Cooper Companies during the 2nd quarter valued at approximately $36,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.